Immune Evasion by Epstein-Barr Virus (Q38597254)

4 September 2017

Immune Evasion by Epstein-Barr Virus (English)

1 reference

evasion of host immune response

4 September 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sytse J Piersma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Emmanuel J H J Wiertz

6

object named as

Emmanuel J H J Wiertz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1

Maaike E Ressing

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Anna M Gram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Marjolein J G Hooykaas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

355-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Role for early-differentiated natural killer cells in infectious mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Interleukin-10 determines viral clearance or persistence in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Animal models of Epstein Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Innate immune control of EBV-infected B cells by invariant natural killer T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Post-translational modifications in signal integration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV latent membrane protein 1 is a negative regulator of TLR9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

RNAs in Epstein-Barr virions control early steps of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Proteins of purified Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt's lymphoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Comparing proteomics and RISC immunoprecipitations to identify targets of Epstein-Barr viral miRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Human tumor virus utilizes exosomes for intercellular communication.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus regulates activation and processing of the third component of complement

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Viral infections in mice with reconstituted human immune system components

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-derived EBNA2 regulates STAT3 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Functional delivery of viral miRNAs via exosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Identification of virus-encoded microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Inflammasomes and anti-viral immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Interference with T cell receptor–HLA-DR interactions by Epstein–Barr virus gp42 results in reduced T helper cell recognition

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus regulates STAT1 through latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

A shutoff and exonuclease mutant of murine gammaherpesvirus-68 yields infectious virus and causes RNA loss in type I interferon receptor knockout cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The viral and cellular microRNA targetome in lymphoblastoid cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus LMP2A imposes sensitivity to apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Innate immunity to virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Development of a human adaptive immune system in cord blood cell-transplanted mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus maintains lymphomas via its miRNAs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Nonhuman primate models for Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Signaling to NF-kappaB: regulation by ubiquitination

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus LF2: an antagonist to type I interferon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Herpes simplex virus type 2 virion host shutoff protein suppresses innate dsRNA antiviral pathways in human vaginal epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_12

10.1007/978-3-319-22834-1_12

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428381%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference